XXXX -enhanced MRI features of @entity3811 on top of chronic gouty involvement in different joints.

@entity1 @entity32 @entity8650 @entity3811 @entity75 @entity2681 @entity102 @entity79 @entity236 @entity2287 @entity2762 @entity414
UNASSIGNED: The aims of the current study are to describe @entity2287 -enhanced MRI features of an acute flare of established @entity3811 in different joints and to examine a possible association between serum @entity414 and MRI signs indicative of ongoing @entity32 and/or @entity75 as well as association with disease characteristics and laboratory findings. Twenty-seven male @entity1 with established @entity102 agreed to participate, mean age 47.6  years, and mean disease duration in months 43.2 (  31.8). For all @entity1 , detailed demographic, disease characteristics, and laboratory findings were obtained and correlated with MRI findings. In 27 @entity1 with established gout, a total of 50 MRI studies were performed of the following joints: feet joints (n   =   23), ankles (n   =   18), knees (n   =   5), and hand and wrist joints (n   =   4). MRI revealed capsular thickening in 19 @entity1 , @entity236 ( @entity236 ) in 15, @entity8650 ( @entity8650 ) in 20, joint effusion in 21, @entity79 in 17, @entity2681 in 4, and @entity2762 in 9 cases. In 17 cases, tophaceous lesions were found. Post contrast MRI showed synovial thickening in seven cases. Positive correlations were observed between serum @entity414 levels and the following MRI findings: capsular thickening (r   =   0.552, p   =   0.003), @entity236 (r   =   0.668, p    <=   0.0001), @entity8650 (r   =   0.559, p   =   0.002), and @entity2762 (r   =   0.513, p   =   0.006). Using MRI in @entity102 , important features can be detected like @entity236 , minute @entity2681 , and @entity32 in post contrast MR images. Serum @entity414 (SUA) was positively correlated with capsular thickening, @entity236 , @entity8650 , and @entity2762 .
